New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States

Karl Kieburtz, Russell Katz, C. Warren Olanow

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish
Pages (from-to)920-927
Number of pages8
JournalMovement Disorders
Volume33
Issue number6
DOIs
StatePublished - Jun 2018

Cite this